Arkolith/Insider Trading/KRTX/Form 4

Wheadon David E.

DirectorKaruna Therapeutics, Inc. (KRTX) · full profile →Form 4 · filed Mar 18, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2024Disposed to issuer(D)990$330.00$327K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 18, 2024Disposed to issuer(D)2K$92.30$176K0
Mar 18, 2024Disposed to issuer(D)9K$201.99$1.7M0
Mar 18, 2024Disposed to issuer(D)25K$235.44$5.9M0
Mar 18, 2024Disposed to issuer(D)5K$227.04$1.1M0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-24-013935) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML